David Ilson, MD, PhD
Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Dr Ilson is a medical oncologist on the Memorial Sloan Kettering Cancer Center’s Gastrointestinal Oncology Service in New York City. He is an attending physician and member at Memorial Hospital and a professor of medicine at Weill Cornell Medical College. He is a member of the GI committees of the national clinical research groups Alliance/CALGB and NRG/RTOG and is co-chair of the NRG Upper GI Cancer Committee. He is also a member of the Upper GI Cancer Guidelines Committee of National Comprehensive Cancer Network (NCCN) and former chairman of the Intergroup Esophageal and Gastric Cancer Task Force Committee. He is an internationally recognized expert in gastrointestinal cancers esophagogastric cancers. His recent global clinical trial development includes TAS102 and Zolbetuximab in gastric cancer and Trastuzumab in esophageal cancer.
Editorial Board (Gastrointestinal Oncology)
Terms of Appointment: October 2012 - December 2018; January 2019 - December 2020; January 2021 - December 2022; January 2023 - July 2024
Associate Editor-in-Chief
Terms of Appointment: August 2024 - July 2026